The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

The obesity market is driving pharma’s return on investment (ROI) upward, with the projected return rising to 5.9% overall in 2024, but only reaching 3.8% if GLP-1 assets are excluded. At the same ...

A simple, freely available analysis tool and hardware for analyzing fruit flies allows opportunities for researchers in ...

The Rivian R3 is poised to undercut Tesla vehicles on price while carrying a lot of the prestige Tesla used to have. Tesla ...

“Brigaid is a company that hires professional chefs to work in school kitchens. We get to work with real ingredients and ...

This study presents a valuable open-source and cost-effective method for automating the quantification of male aggression and courtship in Drosophila melanogaster. The work as presented provides solid ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Game of Thrones set up one of the richest and most complex narratives that TV had ever seen in 2011, yet by the end, it was ...